| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.63B | -3.3% |
| Cost of Revenue | $2.45B | -6.6% |
| Gross Profit | $1.19B | +4.3% |
| R&D Expense | $56.3M | +5.6% |
| SG&A Expense | $720.6M | +13.8% |
| Operating Income | $498.7M | +4.3% |
| Pre-tax Income | $442.9M | +4.5% |
| Income Tax | $115.7M | +10.1% |
| Net Income | $320.3M | +1.9% |
| EPS (Basic) | $1.68 | +5.0% |
| EPS (Diluted) | $1.65 | +5.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $507.7M | +75.9% |
| Accounts Receivable | $466.8M | -12.7% |
| Inventory | $496.8M | -4.7% |
| Current Assets | $1.56B | +9.7% |
| Total Assets | $3.47B | +7.1% |
| Current Liabilities | $785.9M | +0.4% |
| Long-term Debt | $612.6M | -1.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $589.7M | +9.1% |
| Capital Expenditures | $141.3M | -0.7% |
| Investing Cash Flow | -$215.3M | -68.5% |
| Financing Cash Flow | -$150.5M | +59.7% |
| Free Cash Flow | $448.4M | +12.7% |
| Total Liabilities |
| $1.64B |
| +3.7% |
| Stockholders' Equity | $1.85B | +10.1% |